Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post–Tacrolimus

Patiromer Does Not Alter Tacrolimus Pharmacokinetics in Kidney Transplant Recipients When Administered Three Hours Post–Tacrolimus

Background. Hyperkalemia is common in kidney transplant (KTx) recipients. Patiromer, a potassium-binding polymer used to treat acute and chronic hyperkalemia, has the potential to bind charged particles in the gastrointestinal tract and thereby potentially affect the absorption of coadministered dru...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Ole Martin Drevland, MSc, Marte Grasdal, MSc, Rasmus K. Carlsen, MD, Karsten Midtvedt, MD, PhD, Ida Robertsen, PhD, Trond G. Jenssen, MD, PhD, Shadi Alipour, MSc, Nils T. Vethe, PhD, Anders Åsberg, PhD, Geir Mjøen, MD, PhD
التنسيق: مقال
اللغة:English
منشور في: Wolters Kluwer 2024-12-01
سلاسل:Transplantation Direct
الوصول للمادة أونلاين:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001733

الانترنت

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001733

مواد مشابهة